相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting AR-Beclin 1 complex-modulated growth factor signaling increases the antiandrogen Enzalutamide sensitivity to better suppress the castration-resistant prostate cancer growth
Meng Zhang et al.
CANCER LETTERS (2019)
Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype
Yao Xiao et al.
CANCER LETTERS (2019)
ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-B survival signals
Chi-Ping Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS
Wei Zhuo et al.
GASTROENTEROLOGY (2019)
The molecular biology of prostate cancer: current understanding and clinical implications
Jason Gandhi et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2018)
Functional Classification and Experimental Dissection of Long Noncoding RNAs
Florian Kopp et al.
CELL (2018)
Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis
Junpei Wang et al.
DIABETES (2018)
Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models
Yong Luo et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Pretreatment expectations of side effects from endocrine therapy found to influence occurrence
Mary Kay Barton
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells
Ramakumar Tummala et al.
MOLECULAR CANCER THERAPEUTICS (2017)
The EGLN-HIF O2-Sensing System: Multiple Inputs and Feedbacks
Mircea Ivan et al.
MOLECULAR CELL (2017)
Transcriptional and posttranscriptional regulation of HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in esophageal squamous carcinoma cells
C. Lin et al.
ONCOGENE (2017)
Global analysis of ribosome-associated noncoding RNAs unveils new modes of translational regulation
Jeremie Bazin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Extracellular Vesicles in the Adaptive Process of Prostate Cancer during Inhibition of Androgen Receptor Signaling by Enzalutamide
Carolina Soekmadji et al.
PROTEOMICS (2017)
Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells
Yangyang Han et al.
THERANOSTICS (2017)
Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA
Iain M. Dykes et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2017)
Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression
Jiaqi Chen et al.
CANCER LETTERS (2017)
ASC-J9® suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L
Ronghao Wang et al.
CANCER LETTERS (2016)
The Long Noncoding RNA Colon Cancer-associated Transcript-1/miR-490 Axis Regulates Gastric Cancer Cell Migration by Targeting hnRNPA1
Baoguo Zhou et al.
IUBMB LIFE (2016)
Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer
Paul Toren et al.
PLOS ONE (2016)
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients
Nada Lallous et al.
GENOME BIOLOGY (2016)
Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models
Paul Toren et al.
EUROPEAN UROLOGY (2015)
NF-kappa B2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer
Nagalakshmi Nadiminty et al.
MOLECULAR CANCER THERAPEUTICS (2015)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Transcriptional regulatory functions of nuclear long noncoding RNAs
Keith W. Vance et al.
TRENDS IN GENETICS (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Androgen Receptor Roles in the Development of Benign Prostate Hyperplasia
Kouji Izumi et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
Vivek K. Arora et al.
CELL (2013)
Epigenetic regulation by long noncoding RNAs in plants
Jae Bok Heo et al.
CHROMOSOME RESEARCH (2013)
Posttranscriptional Gene Regulation by Long Noncoding RNA
Je-Hyun Yoon et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)
Manav Korpal et al.
CANCER DISCOVERY (2013)
A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
James D. Joseph et al.
CANCER DISCOVERY (2013)
Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells
Monica Ciarlo et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Targeting the Unique Methylation Pattern of Androgen Receptor (AR) Promoter in Prostate Stem/Progenitor Cells with 5-Aza-2′-deoxycytidine (5-AZA) Leads to Suppressed Prostate Tumorigenesis
Jing Tian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The RNA-binding Protein HuR Opposes the Repression of ERBB-2 Gene Expression by MicroRNA miR-331-3p in Prostate Cancer Cells
Michael R. Epis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Parameters for establishing humanized mouse models to study human immunity: Analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rγnull mutation
Michael A. Brehm et al.
CLINICAL IMMUNOLOGY (2010)
eIF2α Phosphorylation Tips the Balance to Apoptosis during Osmotic Stress
Elena Bevilacqua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta et al.
NATURE (2010)
The Role of Androgen Receptor Mutations in Prostate Cancer Progression
G. N. Brooke et al.
CURRENT GENOMICS (2009)
Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression
Ahmad M. Khalil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation
Yuanjie Niu et al.
CANCER RESEARCH (2008)
Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling
Oak D. Jo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cytoplasmic relocalization of heterogeneous nuclear ribonucleoprotein A1 controls translation initiation of specific mRNAs
Anne Cammas et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Subcellular relocalization of a trans-acting factor regulates XIAP IRES-dependent translation
Stephen M. Lewis et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Heterogeneous nuclear ribonucleoprotein C1/C2, MeCP1, and SWI/SNF form a chromatin remodeling complex at the β-globin locus control region
MC Mahajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation
YW He et al.
JOURNAL OF CELL SCIENCE (2005)
分享论文
